Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$300.63 - $371.35 $601,260 - $742,700
-2,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$310.19 - $376.2 $620,380 - $752,400
2,000 New
2,000 $651,000
Q1 2021

May 17, 2021

SELL
$285.92 - $355.13 $3.72 Million - $4.62 Million
-13,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $503,760 - $648,400
2,000 Added 18.18%
13,000 $4.22 Million
Q3 2020

Nov 16, 2020

BUY
$255.22 - $317.0 $2.81 Million - $3.49 Million
11,000 New
11,000 $3.05 Million
Q1 2020

May 15, 2020

SELL
$130.51 - $196.01 $352,377 - $529,227
-2,700 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$159.31 - $223.54 $414,206 - $581,204
-2,600 Reduced 49.06%
2,700 $461,000
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $932,216 - $1.48 Million
5,300 New
5,300 $942,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.